Get the Stockscreener App
7.20
1.98%
0.14
Sophia Genetics Sa stock is traded at $7.20, with a volume of 1.11M.
It is up +1.98% in the last 24 hours and down -9.55% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$7.06
Open:
$7
24h Volume:
1.11M
Relative Volume:
1.86
Market Cap:
$612.92M
Revenue:
$81.18M
Net Income/Loss:
$-80.94M
P/E Ratio:
-6.097
EPS:
-1.1809
Net Cash Flow:
$-55.15M
1W Performance:
-1.37%
1M Performance:
-9.55%
6M Performance:
+42.01%
1Y Performance:
+67.83%
1-Day Range:
$6.83
$7.27
1-Week Range:
$7.01
$7.69
52-Week Range:
$3.75
$8.98
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH vs VEEV, TEM, BTSG, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
7.20 | 612.92M | 81.18M | -80.94M | -55.15M | -1.1809 |
VEEV
Veeva Systems Inc
|
310.94 | 50.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
70.07 | 12.72B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
61.89 | 12.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
105.33 | 8.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.43 | 7.65B | 1.34B | 230.70M | 440.96M | 2.6695 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-20-26 | Initiated | H.C. Wainwright | Buy |
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
SOPHiA GENETICS SA Ordinary Shares (SOPH) Stock Price: Oct 7 Close $7.15 - Gotrade
SOPHiA GENETICS CSO Kevin Puylaert Sells 216 Shares for RSU Tax Withholding on October 5, 2026 - Kalkine Media
SOPHiA GENETICS CMO Philippe Menu Sells 7,394 Shares to Cover RSU Tax Withholdings - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Insider Well Daan Van Sells 6,168 Shares of Company Stock - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 7,394 Shares of Company Stock - MarketBeat
Tax withholding drives legal chief’s 6,168-share sale at SOPHiA GENETICS (SOPH) - Stock Titan
SOPHiA GENETICS Director Ross J. Muken Files Form 144 for Sale of 9,838 Shares Under 10b5-1 Plan - Kalkine Media
An officer plans to sell 19,394 common shares in SOPHiA GENETICS (SOPH). - Stock Titan
An officer proposes selling 6,168 SOPHiA GENETICS (NASDAQ: SOPH) shares after stock grants vest. - Stock Titan
9,838 shares are proposed for sale by Ross J. Muken at SOPHiA GENETICS (SOPH), valued at $79.4K. - Stock Titan
Officer George Cardoza proposes selling 1,592 SOPHiA GENETICS (SOPH) common shares. - Stock Titan
Founder shares feature in Jurgi Camblong’s proposed $530K SOPHiA GENETICS (Nasdaq: SOPH) sale. - Stock Titan
SOPHiA GENETICS CEO Ross Muken Sells 422 Shares to Cover RSU Tax Withholding - Kalkine Media
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares - Eastern Progress
Officer at SOPHiA GENETICS (NASDAQ: SOPH) lines up 774-share sale after 10b5-1 trades - Stock Titan
Planned sale of 422 SOPHiA GENETICS (SOPH) shares disclosed under Rule 144 - Stock Titan
SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance
SOPHiA GENETICS (NASDAQ: SOPH) Insider Xu Zhenyu Retains 552,887 Shares Following Sale - Kalkine Media
SOPHiA GENETICS SA (NASDAQ: SOPH) Executive Menu Philippe Disposes of 5,000 Shares at $7.88 Each - Kalkine Media
SOPHiA GENETICS CSO Xu Zhenyu Sells 4,000 Shares Under Rule 10b5-1 Plan - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeShould You Buy? - marketbeat.com
SOPHiA GENETICS Insider Van Well Daan Sells 6,168 Shares at $7.63 Each (NASDAQ: SOPH) - Kalkine Media
Officer at SOPHiA GENETICS (NASDAQ: SOPH) to sell 6,168 shares - Stock Titan
SOPHiA GENETICS SA (NASDAQ:SOPH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Director Sells $50,812.50 in Stock - MarketBeat
SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares via 10b5-1 Trading Plan - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 8.3%Time to Sell? - MarketBeat
Maven Securities LTD Invests $866,000 in SOPHiA GENETICS SA $SOPH - MarketBeat
SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise - Yahoo Finance
SOPHiA GENETICS (NASDAQ:SOPH): Is Volume Signaling A Shift? - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Sees Large Volume IncreaseHere's Why - marketbeat.com
SOPHiA GENETICS CSO Zhenyu Xu Sells 10,000 Shares Under Rule 10b5-1 Plan - Kalkine Media
Zhenyu Xu Sells 10,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Down 5%Here's Why - MarketBeat
Sophia Genetics SA (SOPH) Peer Comparison – Compare with Others - Value Research
SOPHiA GENETICS (NASDAQ: SOPH) officer to sell 14K founder shares - Stock Titan
SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares Under Rule 10b5-1 Plan - Kalkine Media
SOPHiA GENETICS CTO Abhimanyu Verma Executes Sale of 10,000 Shares in August 2026 - Kalkine Media
SOPHiA GENETICS (NASDAQ: SOPH) director plans $158K stock sale - Stock Titan
SOPHiA (SOPH) Earnings Update: The Available Earnings Metric Delivers a Miss in the Available Record; Share Move: Shares Move Lower 2.31% in Latest TradingEarnings Stability Report - dars.gov.et
SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeHere's What Happened - marketbeat.com
SOPHiA (SOPH) Earnings Update: The Available Earnings Metric Delivers a Miss in the Available Record; Share Move - careplusvn.com
SOPHiA (SOPH) Earnings Update: The Available Earnings Metric Delivers a Miss in the Available Record; Share Move: Shares Move Lower 2.31% in Latest TradingRevenue Surprise History - dars.gov.et
SOPHiA GENETICS Chief Scientific Officer Xu Zhenyu Sells 20,000 Shares Over Three Days - Kalkine Media
SOPHiA GENETICS CPO Manuela Valente Executes Share Option Exercise and Sale - Kalkine Media
SOPHiA GENETICS (NASDAQ: SOPH) officer may sell founder shares - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) officer lines up 10,000-share sale - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) officer plans additional 8,000-share sale - Stock Titan
SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month HighShould You Buy? - MarketBeat
EBIT per share of SOPHiA GENETICS SA – DUS:90B - TradingView
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sophia Genetics Sa Stock (SOPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Xu Zhenyu | Chief Scientific Officer |
Oct 13 '26 |
Sale |
7.18 |
4,000 |
28,727 |
541,493 |
| Camblong Jurgi | Executive Chairman |
Oct 12 '26 |
Sale |
7.26 |
8,500 |
61,671 |
3,387,150 |
| ROSS J MUKEN | Director |
Oct 05 '26 |
Proposed Sale |
8.07 |
9,838 |
79,393 |
0 |
| PHILIPPE MENU | Officer |
Oct 05 '26 |
Proposed Sale |
8.07 |
22,394 |
180,720 |
0 |
| MANUELA VALENTE | Officer |
Oct 05 '26 |
Proposed Sale |
8.07 |
4,240 |
34,217 |
0 |
| GEORGE CARDOZA | Officer |
Oct 05 '26 |
Proposed Sale |
8.07 |
1,592 |
12,847 |
0 |
| JURGI CAMBLONG | Director |
Oct 05 '26 |
Proposed Sale |
8.07 |
65,672 |
529,973 |
0 |
| Valente Manuela | Chief People Officer |
Oct 05 '26 |
Sale |
8.13 |
4,240 |
34,487 |
206,210 |
| Verma Abhimanyu | Chief Technology Officer |
Oct 05 '26 |
Sale |
8.12 |
5,284 |
42,929 |
166,887 |
| Van Well Daan | Chief Legal Officer |
Oct 05 '26 |
Sale |
8.12 |
6,168 |
50,100 |
332,716 |
0.00%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):